Compile Data Set for Download or QSAR
Report error Found 29 Enz. Inhib. hit(s) with all data for entry = 11444
TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616876BDBM616876(US20230279024, Example 30)
Affinity DataIC50: 5nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616878BDBM616878(US20230279024, Example 32)
Affinity DataIC50: 5nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616862BDBM616862(US20230279024, Example 7)
Affinity DataIC50: 5nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616871BDBM616871(US20230279024, Example 22)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616872BDBM616872(US20230279024, Example 25)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616873BDBM616873(US20230279024, Example 26)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616867BDBM616867(US20230279024, Example 15)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616868BDBM616868(US20230279024, Example 16)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616869BDBM616869(US20230279024, Example 18)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616870BDBM616870(US20230279024, Example 19)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616879BDBM616879(US20230279024, Example 33)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616880BDBM616880(US20230279024, Example 36)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616881BDBM616881(US20230279024, Example 37)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616882BDBM616882(US20230279024, Example 38)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616875BDBM616875(US20230279024, Example 29)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616877BDBM616877(US20230279024, Example 31)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616887BDBM616887(US20230279024, Example 52)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616885BDBM616885(US20230279024, Example 47)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616886BDBM616886(US20230279024, Example 49)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616863BDBM616863(US20230279024, Example 8)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616864BDBM616864(US20230279024, Example 9)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616865BDBM616865(US20230279024, Example 13)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616860BDBM616860(US20230279024, Example 3)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616874BDBM616874(US20230279024, Example 27)
Affinity DataIC50: 75nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616884BDBM616884(US20230279024, Example 44)
Affinity DataIC50: 75nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616866BDBM616866(US20230279024, Example 14)
Affinity DataIC50: 75nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616883BDBM616883(US20230279024, Example 40)
Affinity DataIC50: 100nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616859BDBM616859(US20230279024, Example 2)
Affinity DataIC50: 100nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 616861BDBM616861(US20230279024, Example 5)
Affinity DataIC50: 100nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent